Taimed Biologics Inc.
Clinical trials sponsored by Taimed Biologics Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could an infusion every 8 weeks replace daily HIV pills? Results expected May 2027 (estimated)
-
HIV patients may ditch daily pills for Twice-Yearly antibody shots
Disease control CompletedThis study tested a combination of two lab-made antibodies, TMB-365 and TMB-380, in 51 adults with HIV whose virus was already controlled by daily oral medication. The goal was to see if switching to these antibody infusions every 8 weeks could keep the virus suppressed safely. R…
Phase 1/2 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
HIV drug trogarzo gets a speed boost: new shorter injections tested
Disease control CompletedThis study tested whether Trogarzo, an HIV medication, can be given as a quick 30-second injection into a vein or as a shot into a muscle, instead of the usual 15-minute infusion. Researchers enrolled 43 people, including some with HIV and some healthy volunteers, to check safety…
Phase 3 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC